Wednesday, June 10, 2026

pharma Β· Chronic obstructive pulmonary disease (COPD) Β· Partial Epilepsy in Children and Adolescents

Bial Portela &

Bial Portela & clinical programs β€” 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

EU HQ
EMA registrant Type
Company details
Status
Public
HQ
EU
Programs
7
Drugs
7
Patents
3
Intelligence Β· Clinical Programs

Bial Portela & projects

1 ClinicalTrials.gov programs sponsored by Bial Portela &.

Bial Portela & has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. BIA-28-6156-111

    Bial Portela & Companhia S.A.

    Parkinson's disease

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Bial Portela & have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.